Australia markets close in 1 hour 28 minutes

Acasti Pharma Inc. (ACST)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
2.1700-0.0400 (-1.81%)
At close: 4:00PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/03/2021
31/03/2020
31/03/2019
31/03/2018
Total revenue
196
196
0
0
0
Cost of revenue
-
76
-
-
-
Gross profit
-
120
-
-
-
Operating expenses
Research development
3,431
4,173
15,974
28,734
12,133
Selling general and administrative
6,966
6,655
8,464
4,238
3,118
Total operating expenses
9,860
10,836
24,438
32,973
15,252
Operating income or loss
-9,740
-10,716
-24,438
-32,973
-15,252
Interest expense
-
0
247
273.3673
283.4112
Total other income/expenses net
-8,468
-8,805
-1,118
-5,241
-291.1546
Income before tax
-18,130
-19,678
-25,513
-38,620
-16,652
Income tax expense
-
-
-
0
-
Income from continuing operations
-18,130
-19,678
-25,513
-38,620
-16,652
Net income
-18,130
-19,678
-25,513
-38,620
-16,652
Net income available to common shareholders
-18,130
-19,678
-25,513
-38,620
-16,652
Basic EPS
-
-1.36
-2.40
-5.69
-7.62
Diluted EPS
-
-1.36
-2.40
-5.69
-7.62
Basic average shares
-
14,828
10,573
6,786
2,186
Diluted average shares
-
14,828
10,573
6,786
2,186
EBITDA
-
-18,754
-22,946
-36,230
-14,299